Active Not RecruitingNCT05273996
Stress, mood and thinking skills in older adults with depression
About this title
Read the official source — NCT05273996Medication studyAges 65+United States
Understand this study
Who could participate?
Listed age limits: from 65 years.
- Listed locations
- FarmingtonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 28, 2021
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 75
- Sponsor
- David Steffens
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 65 Years
- Official registry ID
- NCT05273996
- Official title
Show the full official title
Phenotype Predictors of Cognitive Outcomes in Geriatric Depression
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Farmington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is David Steffens.
Does this study involve medication?
Yes. The study involves medication, including Sertraline, bupropion, desvenlafaxine.
Who can participate?
Listed age limits: from 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
